Post-treatment Assessment
On completing treatment, patients commenced surveillance imaging as per
RMS2005 protocol[12] for recurrence and complications. In addition,
a multidisciplinary clinic was established by the surgeons and
oncologists to jointly review BP-RMS patients. A full history,
examination and a systematic bladder function assessment were obtained
for all, including frequency-volume-chart, voided volumes,
post-void-residual (PVR) volume, flow studies, continence status and
ultrasound scanning of the upper tracts and bladder. If a problem was
identified, invasive video-urodynamics were performed. The expected
bladder capacity for age (EBCA) was calculated based on the formula 30ml
+ (30ml times age in years) for children above 2 years of age[17]
and 38ml + (2.5ml times age in months) for children less than 2
years[18]. Patients underwent serial bladder assessments as part of
their follow-up. Variations in the documented functional capacity were
oberved but only the most recent assessment reported.